ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
564 hedge funds and large institutions have $33.4B invested in Alexion Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 240 increasing their positions, 194 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
564
Holders Change
-14
Holders Change %
-2.42%
% of All Funds
15.04%
Holding in Top 10
7
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-61.11%
% of All Funds
0.19%
New
55
Increased
240
Reduced
194
Closed
61
Calls
$121M
Puts
$129M
Net Calls
-$7.86M
Net Calls Change
+$4M
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$3.83B |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$198M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$549M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.95B |
| 5 |
5
Millennium Management
New York
|
$157M |
